Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013 (2013), Article ID 240971, 6 pages
http://dx.doi.org/10.1155/2013/240971
Clinical Study

Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22–30 kg·m−2

1Department of Endocrinology and Metabolism, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China
2Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China

Received 22 November 2012; Revised 17 March 2013; Accepted 19 March 2013

Academic Editor: Stephen L. Atkin

Copyright © 2013 Chandrama Shrestha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Buchwald, Y. Avidor, E. Braunwald et al., “Bariatric surgery: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 292, no. 14, pp. 1724–1737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Y. Zhu, M. Zhaohui, X. W. Yang et al., “Effect of laparoscopic roux-en-Y gastroenterostomy with BMI <35 kg/m2 in type 2 diabetes mellitus,” Obesity Surgery, vol. 22, no. 10, pp. 1562–1567, 2012. View at Google Scholar
  3. A. L. DePaula, A. L. V. Macedo, N. Rassi et al., “Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35,” Surgical Endoscopy, vol. 22, no. 3, pp. 706–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. DePaula, A. L. V. Macedo, B. R. Mota, and V. Schraibman, “Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29,” Surgical Endoscopy, vol. 23, no. 6, pp. 1313–1320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, pp. 1288–1295, 2002. View at Google Scholar
  6. J. Y. Myeong, Y. L. Gha, J. J. Chung, H. A. Young, H. H. Seung, and B. K. Jae, “Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor-α,” Diabetes, vol. 55, no. 9, pp. 2562–2570, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Fukuhara, M. Matsuda, M. Nishizawa et al., “Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin,” Science, vol. 307, no. 5708, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Cheng, W. Dong, L. Qian, J. Wu, and Y. Peng, “Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway,” Journal of Molecular Endocrinology, vol. 47, no. 1, pp. 13–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. C. Turner, R. R. Holman, and D. Matthews, “Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations,” Metabolism, vol. 28, no. 11, pp. 1086–1096, 1979. View at Google Scholar · View at Scopus
  10. World Health Organization, “Obesity. Preventing and managing the global epidemic,” Report of a WHO Consultation on Obesity, World Health Organization, Geneva, Switzerland, 1998. View at Google Scholar
  11. B. Zhou, Y. Wu, J. Yang, H. Zhang, and L. Zhao, “Overweight is an independent factor for cardiovascular disease in Chinese populations,” Obesity Reviews, vol. 3, pp. 147–156, 2002. View at Google Scholar
  12. W. P. Jia, K. S. Xiang, L. Chen, J. Lu, and Y. M. Wu, “Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China,” Obesity Reviews, vol. 3, no. 3, pp. 157–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ito, K. Nakasuga, A. Ohshima et al., “Detection of cardiovascular risk factors by indices of obesity obtained from anthropometry and dual-energy X-ray absorptiometry in Japanese individuals,” International Journal of Obesity, vol. 27, no. 2, pp. 232–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Chang, C. Wu, C. Chang et al., “Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoff,” International Journal of Obesity and Related Metabolic Disorders, vol. 27, pp. 253–259, 2003. View at Google Scholar
  15. Z. Lee, J. Critchley, G. Ko et al., “Obesity and cardiovascular risk factors in Hong Kong Chinese,” Obesity Reviews, vol. 3, pp. 173–182, 2002. View at Google Scholar
  16. Y. Kim, K. S. Youn, and H. Choi, “BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey,” Obesity Research, vol. 12, no. 3, pp. 445–453, 2004. View at Google Scholar · View at Scopus
  17. International Obesity Task Force (on behalf of the Steering Committee), The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, World Health Organization Western Pacific Region, Sydney, Australia, 2002.
  18. C. K. Huang, A. Shabbir, C. H. Lo, C. M. Tai, Y. S. Chen, and J. Y. Houng, “Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25–35,” Obesity Surgery, vol. 21, no. 9, pp. 1344–1349, 2011. View at Google Scholar
  19. M. S. Hickey, W. J. Pories, K. G. MacDonald et al., “A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?” Annals of Surgery, vol. 227, no. 5, pp. 637–644, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. P. R. Schauer, B. Burguera, S. Ikramuddin et al., “Effect of laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitus,” Annals of Surgery, vol. 238, no. 4, pp. 467–485, 2003. View at Google Scholar · View at Scopus
  21. G. S. M. Cowan and C. K. Buffington, “Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery,” World Journal of Surgery, vol. 22, no. 9, pp. 987–992, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Campos, R. Ciovica, S. J. Rogers et al., “Spectrum and risk factors of complications after gastric bypass,” Archives of Surgery, vol. 142, no. 10, pp. 969–975, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. M. Swarbrick, K. L. Stanhope, I. T. Austrheim-Smith et al., “Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery,” Diabetologia, vol. 51, no. 10, pp. 1901–1911, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. K. Hindle, C. Edwards, T. McCaffrey, S. W. Fu, and F. Brody, “Reactivation of adiponectin expression in obese patients after bariatric surgery,” Surgical Endoscopy and Other Interventional Techniques, vol. 24, no. 6, pp. 1367–1373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. A. Whitson, D. B. Leslie, T. A. Kellogg et al., “Adipokine response in diabetics and nondiabetics following the roux-en-Y gastric bypass: a preliminary study,” Journal of Surgical Research, vol. 142, no. 2, pp. 295–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Illán-Gómez, M. Gonzálvez-Ortega, I. Orea-Soler et al., “Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery,” Obesity Surgery, vol. 22, no. 6, pp. 950–955, 2012. View at Google Scholar
  27. M. Manco, J. M. Fernandez-Real, F. Equitani et al., “Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 483–490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Krzyzanowska, F. Mittermayer, W. Krugluger, H. P. Kopp, and G. Schernthaner, “Increase in visfatin after weight loss induced by gastroplastic surgery,” Obesity, vol. 14, no. 11, pp. 1886–1889, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. D. G. Haider, K. Schindler, G. Schaller, G. Prager, M. Wolzt, and B. Ludvik, “Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1578–1581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Mingrone and L. Castagneto-Gissey, “Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgery,” Diabetes and Metabolism, vol. 35, no. 6, pp. 518–523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Orea-Soler, F. Illán Gómez, M. Gonzálvez Ortega et al., “Soluble intercellular adhesion molecule-1 and C reactive protein after bariatric surgery,” Endocrinología y Nutrición, vol. 57, no. 3, pp. 90–94, 2010. View at Google Scholar